1. Home
  2. YHC vs PPBT Comparison

YHC vs PPBT Comparison

Compare YHC & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LQR House Inc.

YHC

LQR House Inc.

N/A

Current Price

$1.39

Market Cap

2.2M

ML Signal

N/A

Logo Purple Biotech Ltd.

PPBT

Purple Biotech Ltd.

N/A

Current Price

$1.34

Market Cap

2.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YHC
PPBT
Founded
2021
2010
Country
United States
Israel
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
2.4M
IPO Year
2023
2014

Fundamental Metrics

Financial Performance
Metric
YHC
PPBT
Price
$1.39
$1.34
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 46.9K
41.9K
Earning Date
11-13-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 8.28
N/A
Revenue
★ $1,120,622.00
N/A
Revenue This Year
$1,254.00
N/A
Revenue Next Year
$21.74
N/A
P/E Ratio
$0.15
★ N/A
Revenue Growth
★ 86.42
N/A
52 Week Low
$0.02
$0.41
52 Week High
$2.72
$5.18

Technical Indicators

Market Signals
Indicator
YHC
PPBT
Relative Strength Index (RSI) 43.88 34.93
Support Level $1.24 $1.16
Resistance Level $1.60 $1.60
Average True Range (ATR) 0.09 0.11
MACD 0.32 -0.01
Stochastic Oscillator 47.22 14.81

Price Performance

Historical Comparison
YHC
PPBT

About YHC LQR House Inc.

LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.

Share on Social Networks: